Alcobra Ltd. (ADHD) was a big mover last session with its shares rising over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock has lost nearly 15% in the past one-month time frame.
This biopharmaceutical company has seen no estimate revision in the last 60 days. Meanwhile, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
Alcobra currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Investors interested in the Med-Drugs industry may consider better-ranked stocks like Mallinckrodt plc (MNK), Lannett Company, Inc. (LCI) and Endo International plc (ENDP). While Mallinckrodt and Lannett Company carry a Zacks Rank #1 (Strong Buy), Endo International bears a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALCOBRA LTD ORD (ADHD): Free Stock Analysis Report
MALLINCKRODT PUBLIC LTD CO (MNK): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report
Zacks Investment Research